Daxor Valuation
| DXR Stock | USD 8.18 0.02 0.25% |
At this time, the firm appears to be undervalued. Daxor shows a prevailing Real Value of $11.93 per share. The current price of the firm is $8.18. Our model computes the value of Daxor from reviewing the firm fundamentals such as Current Valuation of 42.93 M, shares outstanding of 4.93 M, and Profit Margin of 4.48 % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Daxor's valuation include:
Undervalued
Today
Please note that Daxor's price fluctuation is not too volatile at this time. Calculation of the real value of Daxor is based on 3 months time horizon. Increasing Daxor's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Daxor stock is determined by what a typical buyer is willing to pay for full or partial control of Daxor. Since Daxor is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Daxor Stock. However, Daxor's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 8.18 | Real 11.93 | Target 23.38 | Hype 8.18 | Naive 8.16 |
The intrinsic value of Daxor's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Daxor's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Daxor helps investors to forecast how Daxor stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Daxor more accurately as focusing exclusively on Daxor's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Daxor's intrinsic value based on its ongoing forecasts of Daxor's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Daxor's closest peers.
Daxor Cash |
|
Daxor Valuation Trend
Daxor's real value is important for investors to make better decisions and a more accurate overall view of Daxor's financial worth over time. Using both Daxor's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Daxor Total Value Analysis
Daxor is currently anticipated to have company total value of 42.93 M with market capitalization of 40.37 M, debt of 840.3 K, and cash on hands of 59.62 K. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Daxor fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
42.93 M | 40.37 M | 840.3 K | 59.62 K |
Daxor Investor Information
About 57.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.13. Some equities with similar Price to Book (P/B) outperform the market in the long run. Daxor recorded a loss per share of 0.09. The entity last dividend was issued on the 5th of January 2018. Based on the analysis of Daxor's profitability, liquidity, and operating efficiency, Daxor may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.Daxor Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Daxor has an asset utilization ratio of 5.82 percent. This connotes that the Company is making $0.0582 for each dollar of assets. An increasing asset utilization means that Daxor is more efficient with each dollar of assets it utilizes for everyday operations.Daxor Ownership Allocation
The market capitalization of Daxor is $40.37 Million. Daxor retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.Daxor Profitability Analysis
The company reported the last year's revenue of 2.13 M. Total Income to common stockholders was 536.33 K with profit before taxes, overhead, and interest of 119.71 K.About Daxor Valuation
The stock valuation mechanism determines Daxor's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Daxor based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Daxor. We calculate exposure to Daxor's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Daxor's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.1 M | 2.2 M | |
| Pretax Profit Margin | 0.25 | 0.24 | |
| Operating Profit Margin | (0.58) | (0.55) | |
| Net Profit Margin | 0.25 | 0.24 | |
| Gross Profit Margin | 0.74 | 0.83 |
Daxor Growth Indicators
Investing in growth stocks can be very risky. If the company such as Daxor does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 4.8 M | |
| Quarterly Earnings Growth Y O Y | -0.364 | |
| Shares Float | 2.1 M |
Daxor Current Valuation Indicators
Daxor's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Daxor's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Daxor, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Daxor's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Daxor's worth.Additional Tools for Daxor Stock Analysis
When running Daxor's price analysis, check to measure Daxor's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daxor is operating at the current time. Most of Daxor's value examination focuses on studying past and present price action to predict the probability of Daxor's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daxor's price. Additionally, you may evaluate how the addition of Daxor to your portfolios can decrease your overall portfolio volatility.